Cantor Fitzgerald Issues Negative Estimate for DRUG Earnings
Bright Minds Biosciences Inc. (NASDAQ:DRUG – Free Report) – Investment analysts at Cantor Fitzgerald lowered their FY2025 earnings per share estimates for Bright Minds Biosciences in a note issued to investors on Thursday, March 13th. Cantor Fitzgerald analyst C. Duncan now anticipates that the company will post earnings per share of ($0.87) for the year, […]
Bright Minds Biosciences Inc. (NASDAQ:DRUG – Free Report) – Investment analysts at Cantor Fitzgerald lowered their FY2025 earnings per share estimates for Bright Minds Biosciences in a note issued to investors on Thursday, March 13th. Cantor Fitzgerald analyst C. Duncan now anticipates that the company will post earnings per share of ($0.87) for the year, […]
